Antitumour metallocenes: Effect of DMSO on the stability of Cp 2TiX2 and implications for anticancer activity

Metal-Based Drugs

Volumn 5, Issue 4, 1998, Pages 207-215

  Mokdsi, George ^a   Harding, Margaret M ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC METAL COMPLEX; DIMETHYL SULFOXIDE; TITANOCENE DICHLORIDE;

ANTINEOPLASTIC ACTIVITY; AQUEOUS SOLUTION; CONFERENCE PAPER; DRUG HYDROLYSIS; DRUG STABILITY; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 0031698551     PISSN: 07930291     EISSN: None     Source Type: Journal    
DOI: 10.1155/mbd.1998.207     Document Type: Article

References (22)

1. Köpf-Maier, P.; Köpf, H. Drugs of the Future 1986, 11, 297
2. Köpf-Maier, P.; Köpf, H. Struct. Bond. 1988, 70, 105
3. Köpf-Maier, P.; Köpf, H. in Metal Compounds in Cancer Chemotherapy Ed. Fricker, S. P.; Chapman & Hall, London, 1994, 109.
4. Berdel, W. E.; Schmoll, H. J.; Scheulen, M. E.; Korfel, A.; Knoche, M. F.; Harstrci, A.; Bach, F.; Baumgart, J.; Sass, G. J. Cancer Res. Clin. Oncol. 1994, 120[Suppl], R172;
5. Moebus, V. J.; Stein, R.; Kieback, D. G.; Runnebaum, I. B.; Sass, G.; Kreienberg, R. Anticancer Research 1997, 17, 815.
6. (2-y)+
7. Toney, J. H.; Marks, T. J. J. Am. Chem. Soc. 1985, 107, 947.
8. Köpf-Maier, P.; Köpf, H. J. Organomet. Chem. 1988, 342, 167.
9. Köpf-Maier, P.; Grabowski, S.; Köpf, H. Eur. J. Med. Chem. 1984, 19, 347.
10. Köpf-Maier, P.; Kahl, W.; Klouras, N.; Hermann, G.; Köpf, H. Eur. J. Med. Chem. 1981, 16, 275.
11. Köpf-Maier, P.; Klapötke, T.; Köpf, H. Inorg. Chim. Acta 1988, 153, 119.
12. Köpf-Maier, P; Grabowski, S.; Liegener, J.; Köpf, H. Inorg. Chim. Acta 1985, 108, 99.
13. Klapötke, T. M.; Köpf, H.; Tornieporth-Oetting, I. C.; White P. S. Organometallics 1994, 13, 3628;
14. Klapötke, T. M.; Köpf, H.; Tornieporth-Oetting, I. C.; White P. S. Angew. Chem. Int. Ed. Engl. 1994, 33, 1518.
15. Köpf-Maier, P.; Tornieporth-Oetting, I. C. Biometals. 1996, 9, 267.
16. Mokdsi, G.; Harding, M.M. J. Organomet. Chem. 1998, in press.
17. The term Cp hydrolysis is used to describe reactions in which the Cp ligands are replaced by, or react with, water and/or DMSO. Hydrolysis (or substitution) of the halide ligands by water and/or DMSO can also occur. These reactions give rise to both soluble hydrolysis products and insoluble precipitates. In 100% DMSO, the mechanism by which the Cp and halide ligands are replaced is not by reaction with water (ie hydrolysis), except for possibly the minor amount of water that is also present in DMSO. For comparative purposes under the three solvent systems studied, the term hydrolysis is used throughout the text.
18. Glasoe, P. K.; Long, F. A. J. Phys. Chem. 1960, 64, 188.
19. Murray, J.H.; Harding, M.M. J. Med. Chem. 1994, 37, 1936.
20. Döppert, K. Makromol. Chem. Rapid Comm. 1980, 1, 519.
21. Köpf-Maier, P.; Hesse, B.; Voigtlander, R.; Köpf, H. J. Cancer Res Clin Oncol. 1980, 97, 31.
22. Köpf-Maier, P.; Klapötke, T.; Köpf, H.; Preiss, F.; Marx, T. Anticancer Res. 1986, 6, 33.